Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 643
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04151381 The Effect of Preoperative Aminophylline |
Aminophylline | SEP | Phase 1 | UNKNOWN | En attente / non publié | Shanghai Jiao Tong University Aff… | Egypt · Beni-Suef University Hospital, Banī Suwayf, E… | 2019-11 → 2019-12 | Ouvrir |
| NCT01240824 Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bla… |
Aminophylline | SEP | Phase 1 | COMPLETED | En attente / non publié | Shanghai Jiao Tong University Aff… | United States · University of Virginia Urology Depart… | 2010-07 → 2011-02 | Ouvrir |
| NCT04551170 Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Yea… |
Theophylline | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hospital Universitari Son Dureta | United States · Vanderbilt University Medical Center,… | 2020-07-13 → 2026-12-31 | Ouvrir |
| NCT01794780 A 1-year Multi-center, Prospective, Cohort Study in Patients With Chron… |
LABA based treatment: indacaterol | SEP | Phase 4 | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | China · Novartis Investigative Site, Beijing, China |… | 2013-02-05 → 2015-05-25 | Ouvrir |
| NCT01017939 A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone Wi… |
Abiraterone acetate | SEP | Phase 1 | COMPLETED | En attente / non publié | Janssen Research & Development, L… | United States, Canada · BC Cancer Agency, Vancouver, … | 2010-01 → 2012-04 | Ouvrir |
| NCT02340520 Enhancement of Corticosteroid Efficacy in COPD |
Theophylline | SEP | Phase 3 | COMPLETED | En attente / non publié | Hospital Universitari Son Dureta | United States · UConnHealth, Farmington, United States | 2014-12 → 2016-08 | Ouvrir |
| NCT04428476 HOPE-2-OLE — Open-label Extension of the HOPE-2 Trial |
Deramiocel (CAP-1002) | Myopathies | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Capricor Inc. | United States · Children's Hospital Colorado, Aurora,… | 2020-08-05 → 2027-03 | Ouvrir |
| NCT07748793 ASSET — Autologous Fat Grafting for the Treatment of Chronic Tendinopat… |
Adipose Stem/Stromal Cells for En… | Myopathies | Non applicable | RECRUITING | En attente / non publié | Weill Medical College of Cornell … | United States · Department of Rehabilitation Medicine… | 2026-10-31 → 2028-07 | Ouvrir |
| NCT02966665 : Vascular Function in Health and Disease |
BH4, L-NMMA, Vitamin C, Vitamin E… | Hypertension | Phase 1 | RECRUITING | En attente / non publié | D. Walter Wray | United States · University of Utah, Salt Lake City, U… | 2008-09 → 2030-08 | Ouvrir |
| NCT03332121 B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma |
B001 | SEP | Phase 1 | COMPLETED | En attente / non publié | Shanghai Pharmaceuticals Holding … | China · Institute of Hematology and Blood Disease Hos… | 2018-03-22 → 2021-02-28 | Ouvrir |
| NCT04660799 A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (… |
Rituximab IV | SEP | Phase 2 | COMPLETED | En attente / non publié | Hoffmann-La Roche | China · Fujian Provincial Cancer Hospital, Fuzhou, Ch… | 2021-02-24 → 2022-10-11 | Ouvrir |
| NCT00244985 Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed … |
Rituximab | SEP | Phase 1/2 | COMPLETED | En attente / non publié | M.D. Anderson Cancer Center | United States · Roswell Park Cancer Institute, Buffal… | 2005-09 → 2012-12 | Ouvrir |
| NCT00244855 Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hod… |
Rituximab | SEP | Phase 2 | COMPLETED | En attente / non publié | M.D. Anderson Cancer Center | United States · Fred Hutchinson Cancer Research Cente… | 2004-05 → 2011-08-29 | Ouvrir |
| NCT05878184 Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) |
SC291 | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sana Biotechnology | United States, Australia · City of Hope, Duarte, Unit… | 2023-05-02 → 2038-11-04 | Ouvrir |
| NCT02992834 Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for C… |
IL-2 pre-treated CD19 cells | SEP | Phase 4 | UNKNOWN | En attente / non publié | jiangjingting | China · First People's Hospital of Changzhou, Changzh… | 2016-12 → 2022-01 | Ouvrir |
| NCT07367685 Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatmen… |
QH103 Cell Injection | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | The Second Affiliated Hospital of… | China · The Second Affiliated Hospital of Fujian Medi… | 2026-05-01 → 2028-12-31 | Ouvrir |
| NCT04806347 Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Rela… |
TCRαβ+/CD19+ depleted Hematopoiet… | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | University of Wisconsin, Madison | Non communiqué | 2026-09 → 2030-06 | Ouvrir |
| NCT02143414 Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and… |
Biopsy Procedure | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Ascension Via Christi Hospitals Wichi… | 2015-06-30 → 2027-06-06 | Ouvrir |
| NCT02427776 SCLEROLYM — A Trial for Evaluating Both Safety and Preliminary Efficacy… |
Autologous CD4+T cells stimulated… | SEP | Phase 1/2 | TERMINATED | En attente / non publié | Imcyse SA | Belgium · Cliniques universitaires Saint-Luc, Brussel… | 2015-01 → 2016-08 | Ouvrir |
| NCT01895439 Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cel… |
Autologous Mesenchymal Stem Cells | SEP | Phase 1/2 | COMPLETED | En attente / non publié | University of Jordan | Jordan · Cell Therapy Center, Jordan University Hospi… | 2012-10 → 2016-02 | Ouvrir |
| NCT05893225 Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain… |
Metformin Hydrochloride 850 mg Or… | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | University Hospital, Antwerp | Belgium · Antwerp University Hospital, Edegem, Belgiu… | 2023-11-23 → 2027-02-28 | Ouvrir |
| NCT07304024 CAPD-LOOT — A Treatment for a Form of Age-Related Central Auditory Proc… |
Clemastine Fumarate Combined With… | SEP | Phase 1/2 | RECRUITING | En attente / non publié | University of Colorado, Denver | United States · University of Colorado Anschutz Medic… | 2025-03-31 → 2028-07 | Ouvrir |
| NCT06330077 MODIF-MS — Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sc… |
Ifenprodil | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Assistance Publique - Hôpitaux de… | France · Groupe Hospitalier Pitié Salpêtrière - APHP,… | 2024-03 → 2027-06 | Ouvrir |
| NCT01451593 Neuroprotection With Phenytoin in Optic Neuritis |
Phenytoin | SEP | Phase 2 | COMPLETED | En attente / non publié | University College, London | United Kingdom · National Hospital For Neurology and … | 2011-11 → 2015-03 | Ouvrir |
| NCT03562975 Upper Extremity Function in Multiple Sclerosis Patients With Advanced D… |
Ocrelizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Carol and Frank Morsani Center for Ad… | 2018-07-23 → 2023-01-11 | Ouvrir |